Northwire Canada EditionThursday, July 23, 2026
Northwire
VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2% VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2%
Production / Operations

Bausch's Thermage reaches five million skin treatments

BHC · Price

Executive Summary

  • Bausch Health’s aesthetic subsidiary, Solta Medical, has surpassed the milestone of 5 million skin tightening treatments performed using its Thermage non-surgical system.
  • The Thermage system utilizes monopolar radiofrequency energy to heat skin layers and stimulate collagen production, offering non-invasive smoothing and tightening for facial, body, and eye areas.
  • It is currently the only non-invasive technology indicated for use on both upper and lower eyelids for wrinkles.

Key Details

  • Milestone: Over 5 million Thermage treatments performed worldwide.
  • Technology: Thermage uses monopolar radiofrequency energy to safely heat skin layers and stimulate natural collagen production.
  • Indications: Used for yearly facial, body, and eye treatments; specifically indicated for wrinkles on upper and lower eyelids.
  • Company: Solta Medical, the aesthetic business of Bausch Health Companies Inc.

Notable Quotes

  • "Thermage has surpassed five million tips used worldwide, a testament to the trusted science behind every treatment... We will continue to advance our technology by investing in research and development, as well as gathering clinical evidence." — Jiny Kim, Senior Vice-President, Solta Medical, Bausch Health
  • "We are proud to celebrate this incredible milestone achieved by Thermage technology... This accomplishment reflects our commitment to innovative solutions in aesthetics, and demonstrates the trust that patients and providers place in our products globally." — Thomas J. Appio, Chief Executive Officer, Bausch Health
Read the original news release →

More from Bausch Health Companies Inc